Trial Profile
A phase III study of NLS-2 in restless legs syndrome (RLS)
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 08 Jul 2019
Price :
$35
*
At a glance
- Drugs NLS-2 (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- 22 Jan 2018 New trial record